ReviewAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2022

The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.

Jay M Edelberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.